丙型肝炎直接抗病毒药物的发展现状
International Journal of Epidemiology and Infectious Disease（2014）
Abstract
慢性丙型肝炎的标准化治疗方案为聚乙二醇IFN联合利巴韦林,但其疗效欠佳,而口服直接抗病毒药物(DAA)的问世给患者带来了新的希望.目前已经上市或在研的DAA主要包括NS3/4A蛋白酶抑制剂、NS5A蛋白酶抑制剂和NS5B聚合酶抑制剂等.此文对这3种DAA的发展现状及其进展作一综述.
MoreTranslated text
Key words
antiviral agents,direct-acting
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined